IRIS Accounts Production v25.1.0.734 06309788 Board of Directors 1.8.23 31.7.24 31.7.24 the manufacture of workwear. 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh063097882023-07-31063097882024-07-31063097882023-08-012024-07-31063097882022-07-31063097882022-08-012023-07-31063097882023-07-3106309788ns15:EnglandWales2023-08-012024-07-3106309788ns14:PoundSterling2023-08-012024-07-3106309788ns10:Director12023-08-012024-07-3106309788ns10:Director22023-08-012024-07-3106309788ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3106309788ns10:SmallEntities2023-08-012024-07-3106309788ns10:AuditExemptWithAccountantsReport2023-08-012024-07-3106309788ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3106309788ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3106309788ns10:FullAccounts2023-08-012024-07-3106309788ns10:OrdinaryShareClass12023-08-012024-07-3106309788ns10:CompanySecretary12023-08-012024-07-3106309788ns10:RegisteredOffice2023-08-012024-07-3106309788ns5:ShareCapital2024-07-3106309788ns5:ShareCapital2023-07-3106309788ns5:RetainedEarningsAccumulatedLosses2024-07-3106309788ns5:RetainedEarningsAccumulatedLosses2023-07-3106309788ns5:PlantMachinery2023-08-012024-07-3106309788ns5:FurnitureFittings2023-08-012024-07-3106309788ns5:MotorVehicles2023-08-012024-07-3106309788ns5:ComputerEquipment2023-08-012024-07-3106309788ns5:OwnedAssets2023-08-012024-07-3106309788ns5:OwnedAssets2022-08-012023-07-3106309788ns5:PlantMachinery2023-07-3106309788ns5:FurnitureFittings2023-07-3106309788ns5:MotorVehicles2023-07-3106309788ns5:ComputerEquipment2023-07-3106309788ns5:PlantMachinery2024-07-3106309788ns5:FurnitureFittings2024-07-3106309788ns5:MotorVehicles2024-07-3106309788ns5:ComputerEquipment2024-07-3106309788ns5:PlantMachinery2023-07-3106309788ns5:FurnitureFittings2023-07-3106309788ns5:MotorVehicles2023-07-3106309788ns5:ComputerEquipment2023-07-3106309788ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-07-3106309788ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-08-012024-07-3106309788ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-07-3106309788ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-07-3106309788ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-07-3106309788ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-07-3106309788ns10:OrdinaryShareClass12024-07-3106309788ns5:CurrentFinancialInstruments2024-07-3106309788ns5:CurrentFinancialInstruments2023-07-3106309788ns5:Non-currentFinancialInstruments2024-07-3106309788ns5:Non-currentFinancialInstruments2023-07-31
REGISTERED NUMBER: 06309788 (England and Wales)




















Report of the Directors and

Unaudited Financial Statements

for the Year Ended 31 July 2024

for

1ST BIOTECH LIMITED

1ST BIOTECH LIMITED (REGISTERED NUMBER: 06309788)

Contents of the Financial Statements
for the Year Ended 31 July 2024










Page

Company Information 1

Report of the Directors 2

Statement of Comprehensive Income 3

Balance Sheet 4

Notes to the Financial Statements 6


1ST BIOTECH LIMITED

Company Information
for the Year Ended 31 July 2024







DIRECTORS: Miss S Cunningham
L Cunningham





SECRETARY: Miss S Cunningham





REGISTERED OFFICE: 19 North Street
Ashford
Kent
TN24 8LF





REGISTERED NUMBER: 06309788 (England and Wales)





ACCOUNTANTS: Calcutt Matthews WBZ Ltd
19 North Street
Ashford
Kent
TN24 8LF

1ST BIOTECH LIMITED (REGISTERED NUMBER: 06309788)

Report of the Directors
for the Year Ended 31 July 2024


The directors present their report with the financial statements of the company for the year ended 31 July 2024.

DIRECTORS
Miss S Cunningham has held office during the whole of the period from 1 August 2023 to the date of this report.

Other changes in directors holding office are as follows:

L Cunningham - appointed 6 February 2024

During the year the company purchased a significant quantity of items at a reduced margin to assist the government during the pandemic.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





L Cunningham - Director


23 April 2025

1ST BIOTECH LIMITED (REGISTERED NUMBER: 06309788)

Statement of Comprehensive Income
for the Year Ended 31 July 2024

31.7.24 31.7.23
Notes £    £   

TURNOVER 723,626 741,446

Cost of sales 459,457 547,214
GROSS PROFIT 264,169 194,232

Administrative expenses 131,972 87,990
132,197 106,242

Interest receivable and similar income 120 34
132,317 106,276

Interest payable and similar expenses 5,716 6,607
PROFIT BEFORE TAXATION 4 126,601 99,669

Tax on profit 33,369 12,200
PROFIT FOR THE FINANCIAL YEAR 93,232 87,469

OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE
YEAR

93,232

87,469

1ST BIOTECH LIMITED (REGISTERED NUMBER: 06309788)

Balance Sheet
31 July 2024

31.7.24 31.7.23
Notes £    £    £   
ASSETS

FIXED ASSETS
Tangible assets 5 47,604 40,160

CURRENT ASSETS
Stocks 3,000 3,000
Debtors 6 1,501,213 1,344,785
Cash at bank and in hand 10,756 31,891
1,514,969 1,379,676
1,562,573 1,419,836

CAPITAL, RESERVES AND LIABILITIES

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 918,772 853,340
SHAREHOLDERS' FUNDS 918,872 853,440

CREDITORS 8 643,701 566,396
1,562,573 1,419,836

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

1ST BIOTECH LIMITED (REGISTERED NUMBER: 06309788)

Balance Sheet - continued
31 July 2024


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 23 April 2025 and were signed on its behalf by:





Miss S Cunningham - Director


1ST BIOTECH LIMITED (REGISTERED NUMBER: 06309788)

Notes to the Financial Statements
for the Year Ended 31 July 2024


1. STATUTORY INFORMATION

1st Biotech Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

1ST BIOTECH LIMITED (REGISTERED NUMBER: 06309788)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024


2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. PROFIT BEFORE TAXATION

The profit is stated after charging:

31.7.24 31.7.23
£    £   
Depreciation - owned assets 7,822 2,778

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Motor Computer
machinery fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 August 2023 30,000 12,545 105,044 5,384 152,973
Additions - - 22,708 - 22,708
At 31 July 2024 30,000 12,545 127,752 5,384 175,681
DEPRECIATION
At 1 August 2023 24,779 11,395 72,066 4,573 112,813
Charge for year 1,305 287 13,419 253 15,264
At 31 July 2024 26,084 11,682 85,485 4,826 128,077
NET BOOK VALUE
At 31 July 2024 3,916 863 42,267 558 47,604
At 31 July 2023 5,221 1,150 32,978 811 40,160

1ST BIOTECH LIMITED (REGISTERED NUMBER: 06309788)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024


5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST
At 1 August 2023
and 31 July 2024 93,066
DEPRECIATION
At 1 August 2023 61,287
Charge for year 7,442
At 31 July 2024 68,729
NET BOOK VALUE
At 31 July 2024 24,337
At 31 July 2023 31,779

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Trade debtors 98,080 119,314
Other debtors 1,403,133 1,225,471
1,501,213 1,344,785

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.7.24 31.7.23
value: £    £   
100 Ordinary 1 100 100

8. CREDITORS
31.7.24 31.7.23
£    £   
Amounts falling due within one year:
Hire purchase contracts 18,768 6,777
Trade creditors 219,393 77,727
Amounts owed to group undertakings 201,336 201,336
Taxation and social security 31,369 71,614
Other creditors 153,513 177,803
624,379 535,257

1ST BIOTECH LIMITED (REGISTERED NUMBER: 06309788)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024


8. CREDITORS - continued
31.7.24 31.7.23
£    £   
Amounts falling due after more than one year:
Bank loans 19,322 29,100
Hire purchase contracts - 2,039
19,322 31,139

Aggregate amounts 643,701 566,396

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 19,322 29,100